Skip to the page

Data / Form D filings / Insignis Therapeutics Inc.

Insignis Therapeutics Inc.: Form D filings

Insignis Therapeutics Inc., a company in North Haven, CT, filed 2 Form D notices with the SEC between 2023 and 2026. The latest, on August 5, 2026, reports $6 million sold of a $8.5 million offering to 4 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
410 SACKETT POINT ROAD BUILDING 20, North Haven, CT, 06473
Phone
(203) 570-8879
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1981826

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 5, 2026New notice$8,500,000$5,999,714$2,500,2864Jun 11, 2026sec.gov
Jun 16, 2023New noticeIndefinite$500,0001Jun 12, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Mingbao ZhangExecutive Officer, Director

Other companies in Connecticut that filed recently

Every Form D from the week of Aug 3, 2026 · All recent filings in Connecticut · All recent Other filings

Read from SEC EDGAR. Amount sold is what Insignis Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.